• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VCEL

VCEL

Vericel Corporation

NASDAQHealthcareBiotechnologyUS

USD34.74

+0.29 (+0.84%)

Rating:B-

Company Profile

CEO

Dominick C. Colangelo

IPO Date

1997-02-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$34.43

Prev. Close

$34.45

Day Low

$34.29

Day High

$35.92

52W Low

$28.95

52W High

$45.97

Market Cap

$1.77B

Volume

0.59M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

25.5%

Avg Negative

15.4%

Avg Neutral

59.1%

News Feed

Vericel to Report Second-Quarter 2021 Financial Results on August 4, 2021

GlobeNewsWire·7/21/2021·↑ positive

Bear of the Day: Vericel (VCEL)

Zacks Investment Research·7/19/2021·↑ positive

Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021

GlobeNewsWire·7/7/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vericel Corporation - VCEL

PRNewsWire·6/29/2021·↓ negative

Why Vericel Tumbled by Nearly 15% on Tuesday

The Motley Fool·6/29/2021·↓ negative

Why Shares Of MediWound And Vericel Fell On Tuesday

Benzinga·6/29/2021·↓ negative

FDA Strikes Off MediWound - Vericel's NexoBrid Biologics License Application; Stocks Drop

Benzinga·6/29/2021·↑ positive

Vericel Provides Regulatory Update for NexoBrid

GlobeNewsWire·6/29/2021·↑ positive

Vericel Announces Appointment of Lisa Wright to Board of Directors

GlobeNewsWire·6/2/2021·↑ positive

Vericel: A Leader In Cell-Based Therapy

Seeking Alpha·5/26/2021·↑ positive